Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
UnitedHealth ( (UNH) ) has shared an update.
On May 12, 2025, UnitedHealth Group announced that CEO Andrew Witty would step down, with Steve Hemsley taking over as CEO while continuing as Board Chair. The company also suspended its 2025 outlook due to higher-than-expected medical expenditures, with plans to return to growth in 2026.
The most recent analyst rating on (UNH) stock is a Buy with a $647.00 price target. To see the full list of analyst forecasts on UnitedHealth stock, see the UNH Stock Forecast page.
Spark’s Take on UNH Stock
According to Spark, TipRanks’ AI Analyst, UNH is a Neutral.
UnitedHealth’s overall score reflects a solid financial position with strong revenue growth and effective cash management. However, declining profitability metrics and bearish technical indicators temper the outlook. The earnings call highlighted both growth opportunities and challenges, affecting sentiment. Valuation remains balanced, offering a moderate dividend yield. Overall, the company is well-positioned but faces near-term challenges.
To see Spark’s full report on UNH stock, click here.
More about UnitedHealth
UnitedHealth Group is a health care and well-being company focused on helping people live healthier lives and improving the health system. It operates through two main businesses: Optum, which provides care aided by technology and data, and UnitedHealthcare, which offers a range of health benefits for affordable coverage and high-quality care access.
Average Trading Volume: 7,959,167
Technical Sentiment Signal: Sell
Current Market Cap: $343.6B
For an in-depth examination of UNH stock, go to TipRanks’ Stock Analysis page.